111 related articles for article (PubMed ID: 7490470)
1. Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa.
Gijbels MJ; HogenEsch H; Bruijnzeel PL; Elliott GR; Zurcher C
J Invest Dermatol; 1995 Dec; 105(6):769-73. PubMed ID: 7490470
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm).
Gijbels MJ; Zurcher C; Kraal G; Elliott GR; HogenEsch H; Schijff G; Savelkoul HF; Bruijnzeel PL
Am J Pathol; 1996 Mar; 148(3):941-50. PubMed ID: 8774148
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm).
Gijbels MJ; Elliott GR; HogenEsch H; Zurcher C; van den Hoven A; Bruijnzeel PL
Exp Dermatol; 2000 Oct; 9(5):351-8. PubMed ID: 11016856
[TBL] [Abstract][Full Text] [Related]
4. Changes in keratin and filaggrin expression in the skin of chronic proliferative dermatitis (cpdm) mutant mice.
HogenEsch H; Boggess D; Sundberg JP
Pathobiology; 1999; 67(1):45-50. PubMed ID: 9873228
[TBL] [Abstract][Full Text] [Related]
5. Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice.
Peuhu E; Salomaa SI; De Franceschi N; Potter CS; Sundberg JP; Pouwels J
PLoS One; 2017; 12(10):e0186628. PubMed ID: 29040328
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructure of epidermis of mice with chronic proliferative dermatitis.
Gijbels MJ; HogenEsch H; Blauw B; Roholl P; Zurcher C
Ultrastruct Pathol; 1995; 19(2):107-11. PubMed ID: 7792947
[TBL] [Abstract][Full Text] [Related]
7. Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice.
HogenEsch H; Dunham A; Seymour R; Renninger M; Sundberg JP
Exp Dermatol; 2006 Oct; 15(10):808-14. PubMed ID: 16984263
[TBL] [Abstract][Full Text] [Related]
8. Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice.
HogenEsch H; Janke S; Boggess D; Sundberg JP
J Immunol; 1999 Apr; 162(7):3890-6. PubMed ID: 10201907
[TBL] [Abstract][Full Text] [Related]
9. Chronic proliferative dermatitis in mice: neutrophil-endothelium interactions and the role of adhesion molecules.
Gallardo Torres HI; Gijbels MJ; HegnEsch H; Kraal G
Pathobiology; 1995; 63(6):341-7. PubMed ID: 8738473
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of chemokines in the skin of chronic proliferative dermatitis mutant mice.
Renninger ML; Seymour R; Lillard JW; Sundberg JP; HogenEsch H
Exp Dermatol; 2005 Dec; 14(12):906-13. PubMed ID: 16274458
[TBL] [Abstract][Full Text] [Related]
11. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.
HogenEsch H; Gijbels MJ; Offerman E; van Hooft J; van Bekkum DW; Zurcher C
Am J Pathol; 1993 Sep; 143(3):972-82. PubMed ID: 8362989
[TBL] [Abstract][Full Text] [Related]
12. SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes.
Liang Y; Sundberg JP
J Dermatol Sci; 2011 Sep; 63(3):148-53. PubMed ID: 21620685
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in the skin of SHARPIN-deficient mice with chronic proliferative dermatitis.
HogenEsch H; Sola M; Stearns TM; Silva KA; Kennedy VE; Sundberg JP
Exp Mol Pathol; 2016 Dec; 101(3):303-307. PubMed ID: 27794420
[TBL] [Abstract][Full Text] [Related]
14. Full-thickness skin grafts from flaky skin mice to nude mice: maintenance of the psoriasiform phenotype.
Sundberg JP; Dunstan RW; Roop DR; Beamer WG
J Invest Dermatol; 1994 May; 102(5):781-8. PubMed ID: 8176263
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12.
HogenEsch H; Torregrosa SE; Boggess D; Sundberg BA; Carroll J; Sundberg JP
Eur J Immunol; 2001 Mar; 31(3):734-42. PubMed ID: 11241277
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex.
Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K
J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492
[TBL] [Abstract][Full Text] [Related]
17. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling.
Potter CS; Wang Z; Silva KA; Kennedy VE; Stearns TM; Burzenski L; Shultz LD; Hogenesch H; Sundberg JP
PLoS One; 2014; 9(1):e85666. PubMed ID: 24465642
[TBL] [Abstract][Full Text] [Related]
18. Harlequin ichthyosis (ichq): a juvenile lethal mouse mutation with ichthyosiform dermatitis.
Sundberg JP; Boggess D; Hogan ME; Sundberg BA; Rourk MH; Harris B; Johnson K; Dunstan RW; Davisson MT
Am J Pathol; 1997 Jul; 151(1):293-310. PubMed ID: 9212754
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a hypertrophic scar model by transplanting full-thickness human skin grafts onto the backs of nude mice.
Yang DY; Li SR; Wu JL; Chen YQ; Li G; Bi S; Dai X
Plast Reconstr Surg; 2007 Jan; 119(1):104-109. PubMed ID: 17255662
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.
Renninger ML; Seymour RE; Whiteley LO; Sundberg JP; Hogenesch H
Exp Dermatol; 2010 Mar; 19(3):252-8. PubMed ID: 19650867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
